On February 27, 2020, the FDA approved an intravenous solution of amisulpride (Barhemsys; Acacia Pharma) to treat and prevent postoperative nausea and vomiting.
John Kassis, PharmD
Advertisement
Articles by John Kassis, PharmD
Advertisement
Latest Updated Articles
Barhemsys (Amisulpride) for Postoperative Nausea and VomitingPublished: June 22nd 2020 | Updated:
Advertisement
Advertisement
Trending on Drug Topics
1
Trump Administration Looking to Bypass PBMs Through Online DTC Pharmacy
2
Pharmacists Now Authorized to Independently Prescribe Buprenorphine
3
FDA Enforces Stricter Vaccine Development, Linking COVID Vaccine to Pediatric Deaths
4
New Research Highlights Dietary Interventions to Potentially Manage Asthma
5
